- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03400319
Obstructive Sleep Apnoea in Adolescents With Thoracic Aortic Aneurysm (OSA in TAA)
April 30, 2021 updated by: University of Zurich
The objective of this prospective cohort study is to determine the prevalence of obstructive sleep apnoea (OSA) in patients with and without thoracic aortic aneurysm.
Study Overview
Status
Completed
Detailed Description
The objective of this prospective cohort study is to determine the prevalence of obstructive sleep apnoea (OSA) in patients with and without thoracic aortic aneurysm.
Study Type
Observational
Enrollment (Actual)
174
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Zurich, Switzerland, 8091
- University Hospital Zurich, Pulmonary Division
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients with and without Thoracic Aortic Aneurysm
Description
Inclusion Criteria:
- Age > 18 years.
- Diagnosis of thoracic aortic aneurysm defined by the following parameters:
Women: at the level of the sinus of valsalva ≥39mm, or ascending aorta ≥42mm. (for controls: <39mm and <42mm respectively); Men: at the level of the sinus of valsalva ≥44mm, or ascending aorta ≥46mm. (for controls: <44mm and <46mm respectively)
Exclusion Criteria:
- Patients on continuous positive airway pressure (CPAP) therapy for OSA at baseline.
- Patients with known central sleep apnoea.
- Patients on morphine or other opioid medication, heroin addiction, alcohol addiction.
- Patients with moderate or severe aortic regurgitation.
- Patients with moderate or severe aortic stenosis.
- Pregnant patients.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Thoracic Aortic Aneurysm
Patients with Thoracic Aortic Aneurysm: Women: at the level of the sinus of valsalva ≥39mm, or ascending aorta ≥42mm.
Men: at the level of the sinus of valsalva ≥44mm, or ascending aorta ≥46mm.
|
No Thoracic Aortic Aneurysm
Patients without Thoracic Aortic Aneurysm: Women: at the level of the sinus of valsalva <39mm, or ascending aorta <42mm.
Men: at the level of the sinus of valsalva <44mm, or ascending aorta <46mm.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prevalence of Obstructive Sleep Apnea
Time Frame: Baseline
|
Prevalence of Obstructive Sleep Apnea according to a Sleep study (The ApneaLink™)
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 5, 2014
Primary Completion (ACTUAL)
March 1, 2020
Study Completion (ACTUAL)
March 1, 2020
Study Registration Dates
First Submitted
January 9, 2018
First Submitted That Met QC Criteria
January 9, 2018
First Posted (ACTUAL)
January 17, 2018
Study Record Updates
Last Update Posted (ACTUAL)
May 3, 2021
Last Update Submitted That Met QC Criteria
April 30, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Nervous System Diseases
- Respiratory Tract Diseases
- Respiration Disorders
- Sleep Disorders, Intrinsic
- Dyssomnias
- Sleep Wake Disorders
- Wounds and Injuries
- Signs and Symptoms, Respiratory
- Aortic Diseases
- Sleep Apnea Syndromes
- Sleep Apnea, Obstructive
- Apnea
- Rupture
- Aneurysm
- Aortic Aneurysm
- Aortic Aneurysm, Thoracic
Other Study ID Numbers
- KEK-ZH-Nr. 2014-0035 CTRL
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obstructive Sleep Apnea
-
LivaNovaRecruitingApnea | Obstructive Sleep Apnea | OSA | Apnea, Obstructive | Apnea+Hypopnea | Apnea, Obstructive Sleep | Hypopnea, SleepUnited States
-
Mauro ManconiCompletedObstructive Sleep Apnea Syndrome | Sleep Apnea, Obstructive | Obstructive Sleep Apnea | OSA | Apnea, Obstructive | OSAHSwitzerland
-
University of California, Los AngelesRecruiting
-
Brigham and Women's HospitalCompletedObstructive Sleep Apnea (OSA)United States
-
State Budgetary Healthcare Institution, National...RecruitingObstructive Sleep Apnea | Obstructive Sleep Apnea-hypopnea | Obstructive Sleep Apnea-hypopnea SyndromeRussian Federation
-
The Hospital for Sick ChildrenCompleted
-
Cryosa, Inc.Active, not recruitingObstructive Sleep Apnea of AdultPanama, Paraguay
-
State Key Laboratory of Respiratory DiseaseCompletedObstructive Sleep Apnea of AdultChina
-
Somnics, Inc.UnknownObstructive Sleep Apnea of AdultTaiwan
-
ApnimedCompletedOSA - Obstructive Sleep ApneaUnited States